Wayne State University, Barbara Ann Karmanos Cancer Institute — Detroit, Michigan

Wayne State University, Barbara Ann Karmanos Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Wayne State University, Barbara Ann Karmanos Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Poniard Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wayne State University, Barbara Ann Karmanos Cancer Institute?

Wayne State University, Barbara Ann Karmanos Cancer Institute has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wayne State University, Barbara Ann Karmanos Cancer Institute conducted?

Wayne State University, Barbara Ann Karmanos Cancer Institute has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is Wayne State University, Barbara Ann Karmanos Cancer Institute accredited by Crixeo Health?

Wayne State University, Barbara Ann Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Wayne State University, Barbara Ann Karmanos Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.